CRMD
CorMedix Inc
7.90$
+1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 17.6% | – | 63.2% | 6.0% | 3.8% | 4.1% | 4.7% | 10.7% | 16.6% | 17.5% | 24.3% | 17.2% | |
| – | -17.6% | – | 36.8% | 94.0% | 96.2% | 95.9% | 95.3% | 89.3% | 83.4% | 82.5% | 75.7% | 82.8% | |
| – | 752.7% | – | 80.8% | 6.3% | 5.5% | 8.2% | 6.1% | 4.9% | 6.7% | 5.7% | 6.6% | 6.0% | |
| – | 1,716.5% | – | 937.7% | 57.4% | 22.8% | 24.8% | 23.9% | 24.4% | 18.3% | 17.0% | 14.8% | 18.6% | |
| – | 5,134.7% | – | 1,934.8% | 122.7% | 54.8% | 44.4% | 46.1% | 40.0% | 37.5% | 32.5% | 33.6% | 35.8% | |
| – | -5,152.3% | – | -1,898.1% | -28.7% | 41.4% | 51.5% | 49.2% | 49.2% | 46.0% | 50.0% | 42.1% | 47.0% | |
| – | 2.2% | – | 0.8% | 0.1% | 0.0% | 0.0% | 0.0% | 0.9% | 1.4% | – | – | – | |
| – | -4,851.5% | – | -1,755.5% | -24.2% | 43.1% | 52.8% | 51.2% | 50.4% | 43.9% | 43.7% | 38.0% | 44.0% | |
| – | 0.0% | – | 0.0% | -1.0% | – | – | 1.3% | -53.7% | 33.0% | 13.4% | 12.5% | 3.5% | |
| – | -4,851.5% | – | -1,755.5% | -24.2% | 43.1% | 52.8% | 49.9% | 104.1% | 10.9% | 30.3% | 25.5% | 40.5% | |
| – | -4,843.2% | – | -1,745.2% | -23.5% | 43.6% | 53.3% | 51.6% | 55.0% | 53.4% | 51.9% | 56.3% | 54.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.